HealthCor Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $38.1M | Sell |
367,765
-391,273
| -52% | -$40.5M | 34.88% | 1 |
|
|
2022
Q3 | $64.3M | Buy |
759,038
+18,090
| +2% | +$1.53M | 8.05% | 1 |
|
|
2022
Q2 | $61.4M | Sell |
740,948
-28,068
| -4% | -$2.33M | 6.17% | 4 |
|
|
2022
Q1 | $59.3M | Buy |
769,016
+609,696
| +383% | +$47M | 3.96% | 4 |
|
|
2021
Q4 | $14.1M | Buy |
+159,320
| New | +$14.1M | 0.77% | 37 |
|
|
2021
Q2 | – | Sell |
-227,450
| Closed | -$17.2M | – | 76 |
|
|
2021
Q1 | $17.2M | Buy |
227,450
+5,240
| +2% | +$396K | 0.61% | 41 |
|
|
2020
Q4 | $19.5M | Buy |
222,210
+207,610
| +1,422% | +$18.2M | 0.75% | 35 |
|
|
2020
Q3 | $1.11M | Buy |
+14,600
| New | +$1.11M | 0.04% | 37 |
|
|
2017
Q1 | – | Sell |
-775,000
| Closed | -$64.2M | – | 37 |
|
|
2016
Q4 | $64.2M | Buy |
+775,000
| New | +$64.2M | 3.63% | 12 |
|
|
2016
Q3 | – | Sell |
-750,000
| Closed | -$58.4M | – | 36 |
|
|
2016
Q2 | $58.4M | Buy |
+750,000
| New | +$58.4M | 3.18% | 9 |
|
|
2015
Q3 | – | Sell |
-162,500
| Closed | -$22.2M | – | 45 |
|
|
2015
Q2 | $22.2M | Buy |
+162,500
| New | +$22.2M | 1.12% | 23 |
|